Invention Grant
- Patent Title: Tricyclic modulators of TNF signaling
-
Application No.: US15829243Application Date: 2017-12-01
-
Publication No.: US10266532B2Publication Date: 2019-04-23
- Inventor: Eric C. Breinlinger , Phil B. Cox , Justin D. Dietrich , Kristine E. Frank , Michael M. Friedman , Huan-Qui Li , Kenton L. Longenecker , Augustine T. Osuma , Ann Marie Rowley , Anil Vasudevan , Noel S. Wilson , Jerome Daanen , Stevan Djuric , Amanda W. Dombrowski , Arthur Gomtsyan , Robert Schmidt
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: C07D521/00
- IPC: C07D521/00 ; C07D471/04 ; C07D471/14 ; C07D487/04 ; C07D498/04 ; C07D498/14 ; C07D498/18 ; C07D498/20 ; C07D498/22 ; C07D519/00 ; C07D471/18 ; C07D491/147 ; C07D491/22
Abstract:
The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.
Public/Granted literature
- US20180179198A1 TRICYCLIC MODULATORS OF TNF SIGNALING Public/Granted day:2018-06-28
Information query
